Dual-domain microchip-based process for volume reduction solid phase extraction of nucleic acids from dilute, large
Carmen R Reedy1, Kristin A Hagan, Briony C Strachan
1Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA.
Analytical Chemistry
|June 10, 2010
Summary
This study presents a novel dual-phase microfluidic device for efficient nucleic acid purification and volume reduction from forensic samples. The device effectively removes inhibitors, ensuring successful downstream polymerase chain reaction (PCR) amplification for both DNA and RNA.
Area of Science:
- Forensic Science
- Biotechnology
- Analytical Chemistry
Background:
- Forensic genetic analysis often requires processing large volumes of dilute biological samples.
- Traditional nucleic acid extraction methods can be inefficient and struggle with inhibitor removal, impacting downstream analyses like PCR.
- Existing microfluidic solid-phase extraction (muSPE) methods may not adequately address volume reduction or inhibitor removal.
Purpose of the Study:
- To develop and validate a novel dual-phase microfluidic device for integrated nucleic acid purification and volume reduction.
- To demonstrate the device's capability in removing common PCR inhibitors found in forensic samples.
- To assess the device's performance for both DNA and RNA purification from various challenging sample types.
Main Methods:
- Development of a dual-phase microfluidic device integrating silica-based and chitosan-based solid-phase extraction (SPE).
- Utilized flow-mediated mixing with a herringbone structure to interface the two SPE phases.
- Tested the device with dilute whole blood, semen, semen stains, and indigo dye-inhibited blood samples for DNA purification.
- Evaluated RNA purification from a dilute semen sample, followed by reverse transcription PCR (RT-PCR).
Main Results:
- The dual-phase device achieved substantial volume reduction (50-fold for DNA, 14-fold for RNA) and effective removal of PCR inhibitors (guanidine, isopropanol, indigo dye).
- Purified DNA and RNA were successfully amplified using PCR and RT-PCR, respectively, outperforming traditional muSPE methods.
- The device demonstrated superior performance compared to traditional muSPE, particularly in inhibitor removal and achieving PCR-amplifiable results from challenging samples.
- The system operated as a closed system, reducing reagent consumption by 2.6-fold and minimizing contamination risks.
Conclusions:
- The developed dual-phase microfluidic device offers an efficient, integrated solution for nucleic acid purification and volume reduction from dilute forensic samples.
- This technology enhances the reliability of downstream genetic analyses by effectively removing PCR inhibitors.
- The device represents a significant advancement for forensic genetic analysis, improving sample processing efficiency and data accuracy.


